Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Endocrinol.

Sec. Neuroendocrine Science

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1580947

This article is part of the Research TopicNeuroprotective and Therapeutic Effects of Progesterone, Allopregnanolone, and Their DerivativesView all 5 articles

Premenstrual dysphoric disorder as a potential predisposing factor for Alzheimer's disease:A review

Provisionally accepted
Jie  YangJie Yang1,2Ming  ChengMing Cheng2ZhaoShu  JiangZhaoShu Jiang2ChunYu  DuChunYu Du3Nan  Jin ZhaoNan Jin Zhao3Zhen  liang LuoZhen liang Luo2*Zhen  ZhangZhen Zhang2*
  • 1Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province, China
  • 2贵州中医药大学 中医养生学, Guiyang, China
  • 3Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd, Qinhuangdao, China

The final, formatted version of the article will be published soon.

Premenstrual dysphoric disorder (PMDD) and Alzheimer's disease (AD) differ significantly in terms of onset period and clinical manifestations. However, recent studies suggest that the two conditions may share potential links at the neuroendocrine and molecular levels.This review synthesizes current research progress and explores the intersecting biological pathways between PMDD and AD, with a particular focus on dynamic fluctuations in estradiol (E2) and allopregnanolone (ALLO), dysregulation of the γ-aminobutyric acid (GABA)ergic system and serotonergic (5-HT) neurotransmitter systems, and sex-specific vulnerability associated with the apolipoprotein E epsilon 4 (APOE ε4) allele.These mechanisms suggest that PMDD may serve as a potential biological precursor state for AD, offering valuable implications for early screening and intervention.The analysis provides new theoretical insights and research directions for identifying high-risk female populations, understanding sex differences in AD pathogenesis, and developing targeted therapeutic strategies.

Keywords: :Premenstrual dysphoric disorder, Alzheimer's disease, neurotransmitters, Hormonal fluctuations, Neuroinflammation

Received: 21 Feb 2025; Accepted: 23 Sep 2025.

Copyright: © 2025 Yang, Cheng, Jiang, Du, Zhao, Luo and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zhen liang Luo, luozhenliang372@gzy.edu.cn
Zhen Zhang, zhangzhen035@gzy.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.